Screening to identify and treat tamoxifen-associated side effects

Cancer Practice

Volumn 8, Issue 5, 2000, Pages 211-214

  Lundberg, Jeremy C ^a   Theobald, Dale ^a   Ahles, Tim A ^b   Bailey, Katharine P ^c   Zabora, James R ^d  

^a Oncology Symptom Control Research   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF NURSING   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXEPIN; DOXORUBICIN; FLUOXETINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT; TAMOXIFEN;

ADULT; ARTICLE; BEHAVIOR THERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG INDUCED DISEASE; FEMALE; HUMAN; MENTAL DISEASE; PSYCHIATRIC DIAGNOSIS; QUALITY OF LIFE; RATING SCALE; SYMPTOMATOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADULT; ALGORITHMS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DECISION TREES; DEPRESSION; DRUG MONITORING; FEMALE; HUMANS; MASS SCREENING; PATIENT CARE PLANNING; PATIENT CARE TEAM; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; TAMOXIFEN;

EID: 0033781706     PISSN: 10654704     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-5394.2000.85003.x     Document Type: Article

References (0)